Page last updated: 2024-10-22

amiodarone and Cholangiitis, Sclerosing

amiodarone has been researched along with Cholangiitis, Sclerosing in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horsley-Silva, JL1
Dow, EN1
Menias, CO1
Smith, ML1
Carballido, EM1
Lindor, KD1
Vargas, HE1

Other Studies

1 other study available for amiodarone and Cholangiitis, Sclerosing

ArticleYear
Docetaxel Induced Sclerosing Cholangitis.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Antineo

2015